Patents Assigned to Bifodan A/S
  • Patent number: 8460917
    Abstract: Novel Lactobacilli strains, Lactobacillus acidophilus strain Lba EB01 (Lba EB01), Lactobacillus paracasei strain Lbp PB01 (Lbp PB01), Lactobacillus acidophilus strain Lba EB02, Lactobacillus plantarum strain Lbpl PB02, Lactobacillus stain Lbxx EB03 and Lactobacillus strain Lbxx PB03, and strains with essentially the same advantageous properties which alone or in combination can be used as probiotics or together with a prebiotic as a synbiotic. The invention also relates to pharmaceutical compositions, dairy products, functional foods, nutraceutical and products for personal care comprising the strains alone or in combination, as well as use of the strain for prevention or treatment of vaginal infections, urogenital infections and gastrointestinal diseases.
    Type: Grant
    Filed: March 21, 2003
    Date of Patent: June 11, 2013
    Assignee: Bifodan A/S
    Inventors: Gunnar Brøndstad, Erik Brandsborg
  • Patent number: 6455052
    Abstract: A composition for forming an enteric coating on a tablet, capsule or pellet for oral ingestion includes a liquid mixture of alginic acid particles dispersed in an aqueous solution of a binding agent of locust bean, gum, gelatine, vegetable hydrocolloids and/or animal protein.
    Type: Grant
    Filed: May 4, 1999
    Date of Patent: September 24, 2002
    Assignee: Bifodan A/S
    Inventors: Jørn Marcussen, Erik Brandsborg
  • Patent number: 6414023
    Abstract: A disinfecting composition includes about 0.01 to 2% by weight 2,4-dichlorobenzyl alcohol, about 0.1 to 10% by weight of glycerylmonolaurate, and about 95 to 99.5 % by weight vehicle such as a mixture of water and alcohol.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: July 2, 2002
    Assignee: Bifodan A/S
    Inventors: Erik Brandsborg, Preben Borelli
  • Patent number: 6251371
    Abstract: The present invention relates to use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and the preparation for this purpose. It is known to use dichlorobenzyl alcohol (2,4-DCBA) as an agent against bacteria and fungi, i.e. as a disinfectant. By the present invention it has, however, surprisingly turned out that dichlorobenzyl alcohol, preferably 2,4-dichlorobenzyl alcohol, is also useful for treatment of inflammation. The invention also relates to a preparation containing dichlorobenzyl alcohol, preferably 2,4-dichlorobenzyl alcohol, for topical treatment of inflammation, which can be applied onto skin or mucosa in the form of an ointment, a cream, a gel or a solution. Thus, the preparation has turned out to be effective against a variety of inflammatory conditions including skin diseases, such as pruritus and psoriasis, insect bites and stings.
    Type: Grant
    Filed: August 30, 1999
    Date of Patent: June 26, 2001
    Assignee: Bifodan A/S
    Inventors: Hans Holmen, Arne Martinus Pedersen